Abstract: Disclosed are systems and methods for reducing video communication bandwidth requirements of a video surveillance network camera system that includes network communication paths between network video cameras producing video streams of scenes observed by the network video cameras and content-aware computer networking devices analyzing by video analytics video visual content of the video streams to provide managed video representing, at specified quality levels, samples of the scenes observed. Distribution of the managed video consumes substantially less network bandwidth than would be consumed by delivery through network communication paths a video stream at the specified quality level in the absence of analysis by the video analytics.

Abstract: The present invention concerns methods and apparatus for identifying and assigning meaning to words not recognized by a vocabulary or grammar of a speech recognition system. In an embodiment of the invention, the word may be in an acoustic vocabulary of the speech recognition system, but may be unrecognized by an embedded grammar of a language model of the speech recognition system. In another embodiment of the invention, the word may not be recognized by any vocabulary associated with the speech recognition system. In embodiments of the invention, at least one hypothesis is generated for an utterance not recognized by the speech recognition system. If the at least one hypothesis meets at least one predetermined criterion, a sword or more corresponding to the at least one hypothesis is added to the vocabulary of the speech recognition system.

Abstract: Described here are substantially pure (17-?)-3-Oxoandrost-4-en-17-yl tridecanoate compositions, methods of their preparation and uses thereof.

Abstract: The present invention relates to processes for the preparation of empagliflozin. In particular, the present invention relates to the preparation of empagliflozin and intermediates thereof. The present invention also relates to co-crystal of empagliflozin and amino acid and amorphous form of empagliflozin.

Abstract: The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone Cmax to serum testosterone Cave of about 2.7 or less. In yet another embodiment, a method for providing a serum concentration of testosterone within a target serum testosterone concentration Cave range for a male subject is provided.

Abstract: Examples of the disclosure enable packet data access to be managed. In some examples, a device is coupled to a wireless network using a first access point name (APN). The wireless network includes a first packet data network (PDN) corresponding to the first APN and a second PDN. A request to couple the device to the wireless network using a second APN corresponding to the second PDN is received. When the device is configured to use a single PDN, a first instruction associated with decoupling the device from the wireless network is transmitted to the first PDN, and a second instruction associated with coupling the device to the wireless network using the second APN is transmitted to the second PDN. Aspects of the disclosure enable controlling or restricting packet data access to manage network resources.

Abstract: A system and method for parallel optimization of database query using cluster cache improves the performance of group by aggregates by avoiding the merge phase of parallel aggregation with the use of dynamic clustering and by caching the clustering information and storing them in local memory of worker thread. The caching of cluster information is based on user configuration to avoid overuse of system memory.

Abstract: Pharmaceutical compositions and methods for treating or preventing bacterial infections are disclosed. The pharmaceutical compositions typically comprise pharmaceutically effective amount of: (a) sulbactam or a pharmaceutically acceptable salt thereof, and (b) at least one beta-lactamase inhibitor or a pharmaceutically acceptable salt thereof, with the provision that the beta-lactamase inhibitor is not sulbactam.

Abstract: A seat adjustment mechanism for an adjustable seat assembly includes an arcuate tilt column; a lift column; a first tilt slider block detachably engaged to the lift column and slideably engaged to the tilt column for moving the lift column between a plurality of tilt positions; and a first lift slider block slideably engaged to the lift column for moving between a plurality of lift positions independent of the plurality of tilt positions. The slider blocks, the lift columns, the tilt columns and the cross brace may be made of dissimilar materials and/or are easily replaced with alternative components.

Abstract: A processing system includes sensor circuitry and processing circuitry. The sensor circuitry is configured to be coupled to force sensor electrodes, and is configured to drive the force sensor electrodes to obtain capacitive measurements. The processing circuitry is operatively connected to the sensor circuitry and configured to aggregate the capacitive measurements into an aggregated measurement, and apply, to the aggregated measurement, a capacitive measurement to temperature mapping to obtain a current temperature of the force sensor electrodes.

Abstract: Histatin formulations include at least two different histatins. Histatins are used before or after laser surgery. Histatins are also used to treat ocular viruses, fungi or parasites. Histatins may be used for corneal wound healing and as a treatment for ocular surface disease in humans and other animals. Histatin formulations for treating ocular wounds or ocular surface disease include a first peptide comprising a first histatin and a second peptide comprising a second histatin. A method of performing corneal laser surgery on at least one eye of a patient includes cutting a cornea of the eye of the patient with a surgical laser and administering a therapeutic amount of at least one medicament comprising at least one peptide to an ocular surface of the eye.

Abstract: The present invention relates to an antioxidant compound having anti atherosclerotic effect and preparation thereof. The present invention more particularly relates to the synthesis of TPP+ coupled esculetin (mitochondria-targeted esculetin [Mito-Esc]) followed by the biological evaluation of Mito-Esc for its ability to attenuate Angiotensin-II-induced atherosclerosis in apolipoproteinE knockout (ApoE?/? mice along with the endothelial cell age-delaying effects of Mito-Esc.

Abstract: Histatins may be used for epithelial wound prevention and healing in animals. Histatins may also be used for infection and disease prevention and healing in animals. For example, histatins may be included in gels, ointments, creams, tissue glues, patches, aerosol sprays, subcutaneous injections, subcutaneous infusions, intradermal injections, intradermal infusions, or any combination of these formulations. In some embodiments, peptide fragments from at least two different histatins are used.

Abstract: In one example, an edge routing device of a service provider network includes one or more network interfaces configured to send and receive packets and a processing unit configured to retrieve, from a packet received via the one or more network interfaces, priority data from an Internet protocol (IP) header of the packet, form a first tag including a first set of data in a first priority field of the first tag, wherein the first set of data represents a first portion of the priority data, form a second tag including a second set of data in a second priority field of the second tag, wherein the second set of data represents a second portion of the priority data, encapsulate the packet with the first tag and the second tag, and forward, via the one or more network interfaces, the encapsulated packet.

Abstract: The present disclosure in particular relates to data processing, and more particularly, to systems and methods for identifying and extracting an informative segment from data objects. In one embodiment, a system for facilitating identification of an informative segment from a data is provided. The system includes one or more processors; and a memory storing processor-executable instructions comprising instructions to generate a customized search query based on one or more input parameters, process the data to obtain a plurality of machine-readable data objects, obtain one or more approximate results corresponding to the informative segment based on the customize search query and the plurality of data objects, validate the one or more approximate results based on a comparison of the one or more approximate results and the data, and provide the validated one or more approximate result to identify the informative segment.

Abstract: The invention relates to the compounds of formula I and formula IA or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I and formula IA; and methods for treating or preventing neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, bipolar disorder, trigeminal neuralgia, attention-deficit hyperactivity disorder (ADHD), schizophrenia, neuropathic pain, seizures, bipolar disorder, mania, phantom limb syndrome, complex regional pain syndrome, paroxysmal extreme pain disorder, neuromyotonia, intermittent explosive disorder, borderline personality disorder, Myotonia congenita and post-traumatic stress disorder.

Abstract: In one embodiment, a system for managing a virtualization environment comprises a plurality of host machines, one or more virtual disks comprising a plurality of storage devices, a virtualized file server (VFS) comprising a plurality of file server virtual machines (FSVMs), wherein each of the FSVMs is running on one of the host machines, and a backup system configured to, in response to a request to access a data item, determine an access frequency for the data item. The backup system is further configured to, in response a request to store a data item, determine a storage tier at which the data item is to be stored in a cloud storage service, wherein the tier is determined based on the access frequency associated with the data item, and store the data item at the determined tier of the cloud storage service.

Abstract: Particular embodiments provide a plurality of host machines, one or more virtual disks comprising a plurality of storage devices, and a virtualized file server (VFS) comprising a plurality of file server virtual machines (FSVMs), wherein each of the FSVMs is running on one of the host machines and conducts I/O transactions with the one or more virtual disks. A distributed health monitoring service (HMS) may be running on each of the host machines running a FSVM. The HMS may monitor the FSVMs to determine whether any of the FSVMs has failed or is having problems. The HMS may detect that a plurality of the FSVMs have failed, wherein the failed FSVMs form a portion of the FSVMs comprising the VFS. For each of the failed FSVMs, the HMS may reassign an IP address corresponding to the failed FSVM to a live one of the FSVMs.

Abstract: In one embodiment, a system for managing a virtualization environment includes a set of host machines, each of which includes a hypervisor, virtual machines, and a virtual machine controller, and a file server splitting system configured to split an existing virtualized file server (VFS) into a set of new virtualized file servers (VFSs), the splitting system configured to select one or more existing file server virtual machines (FSVMs) to be removed from the existing VFS. For each existing FSVM, the splitting system is configured to identify an available FSVM that is separate from the existing VFS, provide resources of the existing FSVM to the available FSVM, incorporate the available FSVM into one of the new VFSs, and remove the existing FSVM from the existing VFS. The splitting system may be further configured to re-direct requests to access storage items served by the existing FSVM to the available FSVM.

Abstract: In one embodiment, a system for managing a virtualization environment comprises a plurality of host machines, one or more virtual disks comprising a plurality of storage devices, a virtualized file server (VFS) comprising a plurality of file server virtual machines (FSVMs), wherein each of the FSVMs is running on one of the host machines, wherein the VFS is configured to detect a failure of one of the FSVMs on a first one of the host machines, wherein the first host machine is located within a first block of host machines. The VFS may then identify a failover path to a second FSVM. For each storage resource associated with the first FSVM, the VFS may migrate the storage resource to the second FSVM.